August 8, 2019 / 5:12 AM / 11 days ago

BRIEF-Vifor Pharma H1 EBITDA Of CHF 254.6 Million, Up 32.6%

Aug 8 (Reuters) - Vifor Pharma AG:

* VIFOR PHARMA GROUP REPORTS STRONG H1 2019 RESULTS AND RAISES FULL-YEAR GUIDANCE

* H1 EBITDA INCREASED TO CHF 254.6 MILLION, UP 32.6%

* H1 SIGNIFICANT REVENUE GROWTH WITH NET SALES OF CHF 913.3 MILLION, UP 22.2%

* IN 2019 AT CONSTANT EXCHANGE RATES, NET SALES ARE EXPECTED TO EXCEED 15%, EBITDA IS EXPECTED TO GROW BETWEEN 25% AND 30% Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below